SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Anticipation around Aerodromes planned unification with Velodrome and expansion from Base to Ethereum and other chains is driving attention, with traders viewing broader liquidity access and evolving tokenomics as potential catalysts. Sentiment is largely bullish amid a strong rebound, though some question the rollouts timing and worry about a sell-the-news reaction or ongoing token emissions.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention over Aetnas weaker 2027 Medicare Advantage star ratings, which traders say could reduce quality bonuses and pressure margins; the contrast with Humanas improved ratings is weighing on sentiment, though some debate whether the setback is already priced in.

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.

Surrozen Inc

Mercks BRUNELLO results for its Wnt-pathway drug are drawing attention, with traders viewing them as potential validation for Surrozens Wnt-based eye-drug pipeline; FDA clearance of SRZNs SZN-8141 IND adds company-specific context. The community is divided over the implications, including possible safety concerns and whether the rally is justified while Surrozens own candidates lack human efficacy data and financing could dilute shareholders.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs rally to fresh highs is being tied to Goldman Sachs Buy upgrade and optimism about sovereign AI demand expanding its market opportunity. Bulls point to strong momentum and possible short covering, while skeptics argue the valuation is stretched.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

Traders are linking NEARs rally to a quantum-resistant upgrade nearing mainnet, with some also pointing to NEAR Intents activity and Arthur Hayes bullish stance. The conversation is largely optimistic about momentum and a breakout, though some traders remain cautious about pullbacks.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is drawing attention for its AI data-center and networking exposure, with traders pointing to bullish analyst coverage and an upcoming earnings report as support for a recovery. Optimism over AI demand is tempered by concerns about volatile price action, valuation, and the earlier share offerings dilutive effect.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorillas proposed U.S. data-center acquisition and expansion plan, announced as a non-binding letter of intent, has drawn attention as traders question how it will be funded before existing AI deployments are completed. Skeptics cite financing uncertainty, potential dilution and execution concerns, while bullish traders see the expansion as a step toward growth in AI infrastructure.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius U.S. defense grant to convert an existing battery line for domestic drone-cell production is the main focus, with bullish traders viewing it as government backing for expansion and NDAA-compliant supply. Others note the project is long-dated and the grant is not a customer order or near-term revenue, while the initial share-price pop quickly faded.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Ubers agreed acquisition of workplace-catering platform ezCater is drawing attention as it expands Uber Eats into corporate and group orders. Some traders view the deal as a growth and diversification opportunity, while others question the spending amid the stocks persistent weakness and concerns about autonomous-vehicle competition.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldmans sharp slide alongside other bank stocks ahead of quarterly results is driving discussion, with traders debating whether lower earnings expectations and softer fixed-income activity point to further pressure or whether the selloff is an overdone buying opportunity. Some also anticipate a rebound if results beat the reduced expectations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NVAX The dilution was NOT done on the FDA approval pump and recent rise in CTB. From the 10-Q, all 17.8 million ATM shares and 6.5 million private placement shares were done in the 3rd quarter, between July 1st and Sept 30th. The FDA approval was on Oct 3rd. 
 
Shares outstanding timeline as taken from the 10-Qs: 
 
94,308,379 as of June 30 
94,404,185 as of July 31 
6.5 million to SK - August 
17.8 million ATM - mid July to late September 
118,730,398 as of September 30 
FDA approval - October 3 
118,790,222 as of October 31 
 
The share price jumped between $7-10 multiple times in Q3, and it was here they saw the opportunity to do the ATM. The CTB was low at the time, so besides the SI the squeeze signal was not strong in Q3. 
 
Shares available surged from mid July to late September, but after Sep 27th they dried up. So that was when they diluted. 
 
There was near zero dilution during the month of October, when CTB started spiking.

Geopolitrader

Sammy Leonidas

IberianBullish

Skyr

Wayne

giuseppe clinco

StockTwits Web

Novavax Inc

 The dilution was NOT done on the FDA approval pump and recent rise in CTB. From the 10-Q, all 17.8 million ATM shares and 6.5 million private placement shares were done in the 3rd quarter, between July 1st and Sept 30th. The FDA approval was on Oct 3rd. 
 
Shares outstanding timeline as taken from the 10-Qs: 
 
94,308,379 as of June 30 
94,404,185 as of July 31 
6.5 million to SK - August 
17.8 million ATM - mid July to late September 
118,730,398 as of September 30 
FDA approval - October 3 
118,790,222 as of October 31 
 
The share price jumped between $7-10 multiple times in Q3, and it was here they saw the opportunity to do the ATM. The CTB was low at the time, so besides the SI the squeeze signal was not strong in Q3. 
 
Shares available surged from mid July to late September, but after Sep 27th they dried up. So that was when they diluted. 
 
There was near zero dilution during the month of October, when CTB started spiking.

P B W

@pwnedbywallstreet Correct, Per SEC Filing, Shares Assigned for Both SKBio (6.5M Assigned &amp; 17.8M for $143M) was in 3rd Q ending 9/30. Ratings prior to those events were below &lt;20%. If i were to guess, Jacobs panicked in 3RD Q w/ USFDA/EMA delays

Und Schwung

DarvasBoxing

 Correct, Per SEC Filing, Shares Assigned for Both SKBio (6.5M Assigned & 17.8M for $143M) was in 3rd Q ending 9/30. Ratings prior to those events were below <20%. If i were to guess, Jacobs panicked in 3RD Q w/ USFDA/EMA delays

@pwnedbywallstreet 118,790,222 is nothing compared to Murderna

 118,790,222 is nothing compared to Murderna

Marco F

@DrSammy Yep this is my guess as well. Just wanted to correct the record, since I&#39;m seeing posts about collusion with shorts to kill a post FDA approval squeeze, but the timeline here does not support that.

Big Daddy Biden

 Yep this is my guess as well. Just wanted to correct the record, since I'm seeing posts about collusion with shorts to kill a post FDA approval squeeze, but the timeline here does not support that.